Literature DB >> 29207041

Mitochondria-mediated damage to dopaminergic neurons in Parkinson's disease (Review).

Xiao-Liang Liu1, Ying-Di Wang2, Xiu-Ming Yu3, Da-Wei Li4, Guang-Ren Li5.   

Abstract

Mitochondria are important organelles in virtually all eukaryotic cells, and are involved in a wide range of physiological and pathophysiological processes. Besides the generation of cellular energy in the form of adenosine triphosphate, mitochondria are also involved in calcium homeostasis, reactive oxygen species production and the activation of the intrinsic cell death pathway, thus determining cell survival and death. Mitochondrial abnormalities have been implicated in a wide range of disorders, including neurodegenerative disease such as Parkinson's disease (PD), and considered as a primary cause and central event responsible for the progressive loss of dopaminergic neurons in PD. Thus, reversion or attenuation of mitochondrial dysfunction should alleviate the severity or progression of the disease. The present review systematically summarizes the possible mechanisms associated with mitochondria‑mediated dopaminergic neuron damage in PD, in an attempt to elucidate the requirement for further studies for the development of effective PD treatments.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 29207041     DOI: 10.3892/ijmm.2017.3255

Source DB:  PubMed          Journal:  Int J Mol Med        ISSN: 1107-3756            Impact factor:   4.101


  7 in total

Review 1.  Persistent remodeling and neurodegeneration in late-stage retinal degeneration.

Authors:  Rebecca L Pfeiffer; Robert E Marc; Bryan William Jones
Journal:  Prog Retin Eye Res       Date:  2019-07-26       Impact factor: 21.198

Review 2.  Association of p53 with Neurodegeneration in Parkinson's Disease.

Authors:  Qiang Luo; Wei Sun; Yi-Fan Wang; Ji Li; Da-Wei Li
Journal:  Parkinsons Dis       Date:  2022-05-11

3.  The Protective Effects of Mogroside V Against Neuronal Damages by Attenuating Mitochondrial Dysfunction via Upregulating Sirtuin3.

Authors:  Hanjiang Luo; Caixia Peng; Xiaofeng Xu; Yuntao Peng; Fang Shi; Qinghua Li; Jianghui Dong; Min Chen
Journal:  Mol Neurobiol       Date:  2022-01-18       Impact factor: 5.590

Review 4.  The Overcrowded Crossroads: Mitochondria, Alpha-Synuclein, and the Endo-Lysosomal System Interaction in Parkinson's Disease.

Authors:  Kai-Jung Lin; Kai-Lieh Lin; Shang-Der Chen; Chia-Wei Liou; Yao-Chung Chuang; Hung-Yu Lin; Tsu-Kung Lin
Journal:  Int J Mol Sci       Date:  2019-10-25       Impact factor: 5.923

5.  Transcriptome Analysis of Induced Pluripotent Stem Cells and Neuronal Progenitor Cells, Derived from Discordant Monozygotic Twins with Parkinson's Disease.

Authors:  Ivan N Vlasov; Anelya Kh Alieva; Ekaterina V Novosadova; Elena L Arsenyeva; Anna V Rosinskaya; Suzanna A Partevian; Igor A Grivennikov; Maria I Shadrina
Journal:  Cells       Date:  2021-12-09       Impact factor: 6.600

Review 6.  Contribution of Mitochondrial Dysfunction Combined with NLRP3 Inflammasome Activation in Selected Neurodegenerative Diseases.

Authors:  Anna Litwiniuk; Agnieszka Baranowska-Bik; Anita Domańska; Małgorzata Kalisz; Wojciech Bik
Journal:  Pharmaceuticals (Basel)       Date:  2021-11-25

7.  PIAS2-mediated blockade of IFN-β signaling: a basis for sporadic Parkinson disease dementia.

Authors:  Joana Magalhaes; Emilie Tresse; Patrick Ejlerskov; Erling Hu; Yawei Liu; Andrea Marin; Alexia Montalant; Letizia Satriano; Carsten Friis Rundsten; Eva Maria Meier Carlsen; Rasmus Rydbirk; Ali Sharifi-Zarchi; Jesper Bøje Andersen; Susana Aznar; Tomasz Brudek; Konstantin Khodosevich; Marco Prinz; Jean-François Marie Perrier; Manu Sharma; Thomas Gasser; Shohreh Issazadeh-Navikas
Journal:  Mol Psychiatry       Date:  2021-07-08       Impact factor: 15.992

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.